(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

APOMIVIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

APOMIVIR

ST13

US500000077787861

Class

5

Filing

77787861

Registration

3887375

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

02/11/2021

Trademark type

Word

Nice classes

5

Filing date

07/23/2009

Registration date

12/07/2010

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/11/2021

Last transaction

02/11/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/10/2010

First use in commerce

02/10/2010

Drawing code

4

Owner type

03

Owner location

Tapei City, TW

Examiner

ALI, STEPHANIE

Law office

L90

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Far East Bio Tec Co., Ltd.

Representatives

JOSEPH A. BRUCE Bruce Stone LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Calcium supplements; Cough drops; Cough expectorants; Dietary and nutritional supplements; Dietary and nutritionally fortified food products adapted for medical use; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary drink mix for use as a meal replacement; Dietary fiber as an additive for food products; Dietary food supplements; Dietary supplemental drinks; Dietetic foods adapted for medical use; Dietetic sugar for medical use; Enzyme food supplements; Food for medically restricted diets; Gluten-free food to accommodate special medical and health conditions; Herbal supplements; Liquid nutritional supplement; Mineral nutritional supplements; Multivitamin preparations; Natural herbal supplements; Nutraceuticals for use as a dietary supplement; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Nutritional supplement in the nature of a nutrient-denseprotein-based drink mix; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders ; Pharmaceutical preparations for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Plant extracts for medicalveterinary and pharmaceutical purposes; Powdered nutritional supplement drink mix

Publications

History of USPTO decisions and trademark events.

37 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

02/11/2021

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/11/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/11/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/11/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

11/10/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/07/2019

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/28/2016

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/28/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/28/2016

E815

TEAS SECTION 8 & 15 RECEIVED

04/21/2016

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/07/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/16/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

12/07/2010

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/03/2010

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

11/02/2010

ALIE

ASSIGNED TO LIE

10/29/2010

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/18/2010

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/23/2010

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/23/2010

IUAF

USE AMENDMENT FILED

08/24/2010

EISU

TEAS STATEMENT OF USE RECEIVED

08/24/2010

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

06/08/2010

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/13/2010

PUBO

PUBLISHED FOR OPPOSITION

04/13/2010

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/05/2010

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/03/2010

XAEC

EXAMINER'S AMENDMENT ENTERED

03/03/2010

ALIE

ASSIGNED TO LIE

03/03/2010

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/03/2010

GNEA

EXAMINERS AMENDMENT E-MAILED

03/03/2010

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/03/2010

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/03/2009

GNRT

NON-FINAL ACTION E-MAILED

11/03/2009

CNRT

NON-FINAL ACTION WRITTEN

11/03/2009

DOCK

ASSIGNED TO EXAMINER

10/26/2009

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/27/2009

NWAP

NEW APPLICATION ENTERED

07/27/2009

Continuous trademark protection

Get notified about every new filing that threatens APOMIVIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.